---
layout: post
title: "港股三叶草生物涨幅扩大至30%"
date: 2022-05-23 10:01:19 +0800
categories: zhengquanshibao·quanzhongshe
tags: 证券时报·券中社新闻
---
<!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/116.02197" data-code="02197|116|5" data-code2="02197|116|3|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=116.02197&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 02197_0" data-code="K 02197|116|5" data-code2="K 02197|116|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p> 券中社5月23日讯，港股三叶草生物涨幅扩大至30%，延续上周涨势，二价新冠候选疫苗开发推进到临床开发阶段。</p><p class="em_media">（文章来源：证券时报·券中社）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202205232387769980>

[返回证券时报·券中社新闻](//finews.withounder.com/category/zhengquanshibao·quanzhongshe.html)｜[返回首页](//finews.withounder.com/)